About Ils Labs India Private Limited
Data last updated:
Ils Labs India Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 December 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24299TG2021PTC157525. Its GSTIN is 36AAGCI4346G1ZK (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹20,410. It is led by directors including Shrihari Pulagam and Suryanarayana Reddy Pulagam.
Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.97 Lakh, a decline of 28% compared to the previous year. For the same year it recorded a net loss of ₹1.06 Cr and EBITDA of -₹1.05 Cr.
The company is associated with 1 brand: Renovis Pharma.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website renovis-labs.com.
Company details
Contact details
Ils Labs India Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressGround Floor Vijetha Midas Touch Apts Sy No 6, White Field Road Kondapur, Hyderabad, Telangana, India – 500084
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Ils Labs India operates one associated brand: Renovis Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Serves as a CDMO specializing in drug development services. | renovis-labs.com |
Business activity
The main business activity of Ils Labs India is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products |
To see the full business activity and turnover split of Ils Labs India Private Limited, buy the company report.
Financials of Ils Labs India Private Limited
FY 2025 filings availableIls Labs India Private Limited reported revenue of ₹8.97 Lakh (down 28% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 28% in the latest year. EBITDA rose 62% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹1.05 Cr | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹1.06 Cr | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | ||||
| Net Profit Margin | ||||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Ils Labs India Private Limited, buy the company report.
Board of directors of Ils Labs India Private Limited
Ils Labs India has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shrihari Pulagam Also directs: Woodsbury Ventures LLP, Incor Lake City Projects Private Limited, Incor Infrastructure Private Limited and 5 more | Director | 10 May 2022 | 4 Years 6 Months | Current |
| Suryanarayana Reddy Pulagam Also directs: Gajularamaram LLP, Woodsbury Ventures LLP, Incor Lake City Projects Private Limited and 5 more | Director | 19 Sep 2022 | 4 Years 1 Months | Current |
| Javed Iqbal | Director | 28 Jan 2022 | 4 Years 9 Months | Current |
| Aman Iqbal | Director | 01 Dec 2021 | 4 Years 11 Months | Current |
Peer comparison
Ils Labs India Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of chemicals and chemical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Agrarian Seeds Private Limited | ₹9.06 Lakh (FY 2024) | -76.0% | Daryapur, Maharashtra, India | |||
| Bonitochem Industries Private Limited | ₹9.04 Lakh (FY 2025) | Bharuch, Gujarat, India | ||||
| Apsada Enterprises Private Limited | ₹9 Lakh (FY 2025) | Dankuni, West Bengal, India | ||||
| Shree Murlidhar Lifescience Private Limited | ₹8.98 Lakh (FY 2025) | 138.0% | Sinnar, Maharashtra, India | |||
| Quality Chemolub P Ltd | ₹8.97 Lakh (FY 2025) | 189.0% | Mumbai, Maharashtra, India | |||
| Ils Labs India Private Limitedthis company | ₹8.97 Lakh (FY 2025) | -₹1.06 Cr | -28.0% | Hyderabad, Telangana, India | ||
| Thinqcolour Private Limited | ₹8.95 Lakh (FY 2024) | Aligarh, Uttar Pradesh, India | ||||
| Agewin Health Care Private Limited | ₹8.91 Lakh (FY 2025) | -22.0% | Noida, Uttar Pradesh, India | |||
| Medella Softgel Private Limited | ₹8.86 Lakh (FY 2025) | Kathua, Jammu and Kashmir, India | ||||
| M.S Agro Care Private Limited | ₹8.78 Lakh (FY 2022) | Medak, Telangana, India | ||||
| Aavishkar Chemicals Private Limited | ₹8.58 Lakh (FY 2025) | 7.0% | New Delhi, Delhi, India |
To see the full peer comparison of Ils Labs India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ils Labs India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ils Labs India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ils Labs India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAGCI4346G1ZK | Telangana | Active | 05 Jan 2022 |
To see the full GST registrations and return filing status of Ils Labs India Private Limited, buy the company report.
Recent activity
Ils Labs India Private Limited has 8 board changes on record since 2021: 4 appointments and 4 cessations. The latest: Shrihari Pulagam ceased to be Additional Director on 26 Sep 2022.
Frequently asked questions
Ils Labs India is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 December 2021 (5+ years old) and is registered under CIN U24299TG2021PTC157525.
Ils Labs India has 4 current directors:
- Shrihari Pulagam - Director
- Suryanarayana Reddy Pulagam - Director
- Javed Iqbal - Director
- Aman Iqbal - Director
The latest financial statements of Ils Labs India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 26 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Ils Labs India is 36AAGCI4346G1ZK, registered in Telangana.
The CIN (Corporate Identification Number) of Ils Labs India is U24299TG2021PTC157525. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ils Labs India was incorporated on 01 December 2021, making it 5+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Ils Labs India by revenue are Agrarian Seeds Private Limited, Bonitochem Industries Private Limited, Apsada Enterprises Private Limited, Shree Murlidhar Lifescience Private Limited, Quality Chemolub P Ltd and 5 more, all in the same principal business activity (manufacture of chemicals and chemical products).
Shrihari Pulagam ceased to be Additional Director on 26 Sep 2022. Javed Iqbal ceased to be Director on 25 Sep 2022. Suryanarayana Reddy Pulagam was appointed as Director on 19 Sep 2022. Ils Labs India has 8 board changes on record in total.
Ils Labs India can be reached through the website renovis-labs.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Ils Labs India is at Ground Floor Vijetha Midas Touch Apts Sy No 6, White Field Road Kondapur, Hyderabad, Telangana, India – 500084.
Ils Labs India operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
